Government & Administrators
Slash subsidy waste. Build real-time registries. Deploy genomics at population scale.
Talk to an Expert
Neotech World Lab
From Unknowns to Outcomes.
India's precision-medicine diagnostics partner, translating genomic science into accessible, clinically actionable healthcare outcomes.
How genomics help improve patient care
0.0%
lower treatment costs
0.0%
fewer ADRs (Adverse Drug Reactions)
0.0%
fewer hospital readmissions
12 → 4
one patient's medication load reduced — stabilizing treatment and preventing hospitalization
0%
rise in global PGx (pharmacogenomics) adoption
Genomics-enabled public health programs are accelerating precision prevention, screening and disease surveillance in India
Sources: Skokou et al., Clinical implementation of preemptive pharmacogenomics in psychiatry. EBioMedicine (2024) PMID 38364700; Sahana et al., Pharmacogenomic landscape of Indian population using whole genomes. Clin Transl Sci (2022) PMID 35338580
Strategic Alliance
India–Japan
Partnership Strengthening Healthcare Bonds.
Neotech's India-Japan partnership reflects the shared priorities of both governments — bringing Japanese-style laboratory standards into India to accelerate early cancer detection and strengthen treatment pathways. This strategic partnership with DCO Inc., Japan brings internationally validated diagnostic technology and quality practices into the Indian healthcare ecosystem, anchoring Neotech's positioning in government and institutional programmes.
Japanese-Standard Laboratory Practice
Internationally validated quality systems and diagnostic protocols, brought into Indian clinical practice.
Government-Aligned Mission
Working in line with the healthcare priorities of both nations, at population scale.
Cross-Border Scientific Depth
Two research cultures, one shared standard of evidence behind every result delivered.
Tetsuji Yamada
Chairman & Representative Director
The Challenge
Prescriptions and diagnostics still miss the patients they were meant for.
<5%
South Asian representation in the global genetic reference databases most tests still rely on1
~90%
of patients carry at least one variant that changes how a drug will act on them2
Global genomic datasets often underrepresent Indian populations, limiting the relevance of some risk scores and genetic insights. Neotech combines Indian population-focused genomic data to translate genetic insights into more informed diagnosis, treatment and prevention decisions.
1 Sirugo, Williams & Tishkoff (2019). The Missing Diversity in Human Genetic Studies. Cell.
2 Roden, McLeod, Relling et al. (2019). Pharmacogenomics. The Lancet.
The Gap Between Testing and Treatment
Genetic information is valuable only when it reaches the right test at the right time — helping guide diagnosis, treatment selection and patient outcomes.
Prescribing Without Genetic Insights
Prescribing medicines without knowing how a patient's genes may affect the drug. This can lead to side effects, poor response, or the need to change treatment.
Results After the Decision
When genetic testing is offered after treatment decisions are made, the results often become just documentation instead of helping guide the right treatment at the right time.
The Solution
Multiple domains. Integrated expertise. Consistent rigor.
Who We Serve
One lab, six ways to begin.
From population-scale health programmes to a single patient's health story. Precision genomics meets every level of the system.
Hospitals & Clinics
Diagnose with precision. Guide targeted therapy with companion diagnostics. Replace prescribing guesswork with pharmacogenomic evidence.
Talk to an Expert
Pharma & Biotech
Enable drug discovery, companion diagnostics, and patient-genotype analysis.
Talk to an Expert
Diagnostic Labs
Expand your menu across five validated clinical specialties. Compete on genomic depth, not volume alone.
Talk to an Expert
Corporates & CSR Teams
Screen early with carrier and metabolic-risk panels. Prevent later. Turn wellness budgets into measurable outcomes.
Talk to an Expert
Patients & Communities
Understand your own biology, from nutrigenomics to hereditary risk. Make informed choices. Take an active role in your health story.
Talk to an Expert
Testing Panels
Testing Panels by Specialty
Neurology & Psychiatry
From epilepsy to mood disorders, genomics guides diagnosis and treatment across the full neuropsychiatric spectrum.
Nephrology
Early genetic insight into kidney disease risk, and the dosing precision that protects kidney function during treatment.
Endocrine & Diabetes
Predict Type 2 Diabetes risk and its complications before they appear, and personalize diabetic medication from day one.
Dermatology
The most powerful tool for predicting and protecting your skin health is your own DNA.
Cardiology
From drug sensitivity to inherited heart conditions, precision cardiology starts with a genetic baseline.
Every panel includes personalized lifestyle guidance — nutrition, fitness, and early risk management tailored to your results.
Cardiology and Endocrine & Diabetes panels are also available combined as a single Cardio-Metabolic panel for overlapping risk profiles.
Corporate Overview
Our mission is to make actionable, evidence-based genomic insight accessible to clinicians, hospitals, corporates, and government health programmes across India.
242+
Validated diagnostic assays
Clinical panels across five specialties, engineered under one quality system.
Integrated Genomics Platform
NGS · Microarray · qPCR · Bioinformatics
Advanced sequencing, genotyping and bioinformatics capabilities supporting scalable, end-to-end genomic testing.
Quality & Compliance
Accredited, audited, accountable.
SOPs
Documented Standard Operating Procedures governing pre-analytical, analytical, and post-analytical phases, under Good Laboratory Practices (GLP) with full chain-of-custody tracking
Quality Assurance
NABL accredited (ISO 15189) and ISO 9001:2015 certified, with Internal Quality Control (IQC) and participation in External Quality Assurance Schemes (EQAS/PT)
Data Security
ISO 27001:2013 certified, with data confidentiality and patient-information handling aligned with HIPAA and applicable regulatory requirements
Leadership
Qualified laboratory directors, geneticists, and technologists overseeing result validation and clinical sign-off, guided by ACMG, CPIC, and FDA pharmacogenomic labeling standards
NABLISO 15189ISO 9001ISO 27001ACMGCPICHIPAAFDA
Infrastructure & Technology
The platform behind the precision.
Next-Generation Sequencing
Next-Generation Sequencing (NGS) for targeted panels, Whole Exome Sequencing, Whole Genome Sequencing, and broader genomic assays
Microarray Systems
High-throughput microarrays for large-scale genotyping
Real-Time PCR
Real-time PCR (qPCR) and allele-specific genotyping platforms
Healthcare Software & Digital Solutions
Intelligent platforms that streamline clinical workflows, genomic data interpretation, analytics, reporting, and patient management — enabling faster, data-driven healthcare decisions
Bioinformatics
Advanced bioinformatics, variant-annotation pipelines, and Deletion/Duplication (Del/Dup) analysis for accurate clinical interpretation
LIMS Platform
LIMS-enabled workflow ensuring sample traceability and audit-ready record-keeping
Why Neotech
The rigor holds all the way down.
Every panel we deliver rests on two foundations — peer-reviewed research and accredited quality systems.
Published Research & Clinical Expertise
Neotech's work is supported by multiple peer-reviewed publications, reflecting our focus on Indian population genomics, clinical research and evidence-based genomic testing.
Accredited Genomics Expertise
Neotech World Lab offers NABL-accredited genetic testing, reflecting rigorous quality standards across our testing and reporting workflows.
01Quality-assured molecular and genomic diagnostics under a documented QMS
02
Multi-specialty testing spanning cardiology, nephrology, endocrinology, dermatology, and neuropsychiatry, unified under one quality system
03
Scientifically credentialed leadership with proven government and institutional engagement
04
Genomic Interpretation
Genomic insights supported by Indian population data and context, helping improve the relevance of genetic risk assessment, variant interpretation and personalized treatment decisions for Indian patients.